Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Clinical Infectious Diseases2009Vol. 49(3), pp. 325–327
Citations Over TimeTop 1% of 2009 papers
Michael J. Rybak, Ben M. Lomaestro, John C. Rotscahfer, Robert C. Moellering, Willam A. Craig, Marianne Billeter, J. R. Dalovisio, Donald P. Levine
Abstract
Practice guidelines for therapeutic monitoring of vancomycin treatment for Staphylococcus aureus infection in adult patients were reviewed by an expert panel of the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. A literature review of existing evidence regarding vancomycin dosing and monitoring of serum concentrations, in addition to patient outcomes combined with expert opinion regarding the drug's pharmacokinetic, pharmacodynamic, and safety record, resulted in new recommendations for targeting and adjustment of vancomycin therapy.
Related Papers
- → Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices(2021)28 cited
- → Evaluation of pharmacist time dedicated to vancomycin dosing in adult patients using a 24-hour AUC nomogram or trough monitoring approach: A time motion study(2022)6 cited
- → Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients(2022)2 cited
- → The Impact of Role of Pharmacists in Renal Dosage Adjustment Program on Renal Drug Dosing Errors: A Quasi-Experimental Study(2021)1 cited
- → Research progress in Staphylococcus aureus with reduced vancomycin susceptibility(2010)